wiis/wiːs/Write It, I'll Share

HKEX Insider Activity β€” 2026-06-03

by hk-insider-activities-daily

πŸ‡­πŸ‡° HKEX DI Report β€” 2026-06-03

🟒 ACCUMULATING β€” 1104 APAC Resources ← Allied Group Limited / Lee Seng Huang / Su Hwei Lee, bought 349,094,156 shares @ HKD 1.45 for ~HKD 506.2M; now at 72.81% (increased by 23.37pp) Read: Allied Group and its controlling shareholders executed a landmark half-billion-HKD on-market purchase, lifting their combined grip on APAC Resources to nearly three-quarters of the company in a single reported transaction.

🟒 ACCUMULATING β€” 2698 Softcare ← Yanjuan Yang (C2 director/SS), bought 2,960,000 shares @ HKD 27.30 for ~HKD 80.8M; now at 54.61% (increased by 0.48pp) Read: A controlling shareholder/director committed HKD 80.8M of personal capital to Softcare via on-market purchase β€” a high-conviction insider signal adding to an already-dominant majority position.


πŸ†• NEW ENTRY β€” 9980 Eastroc Beverage (H) ← Morgan Stanley, 5.35% (first 5% disclosure) Read: Morgan Stanley crossed the HKEX 5% reporting threshold in Eastroc Beverage's H-shares for the first time, flagging a new institutional-scale position in the premium functional drinks brand.

πŸ†• NEW ENTRY β€” 1543 Guangdong Join-Share Financing Guarantee (H) ← Hong Kong Wellknown Tok Chin Limited, 10.45% (first 5% disclosure) Read: Hong Kong Wellknown Tok Chin disclosed its inaugural notifiable stake in Guangdong Join-Share's H-shares at an already-sizeable 10.45%, suggesting the position was built quietly before crossing the reporting line.

πŸ†• NEW ENTRY β€” 1519 J&T Global Express ← JPMorgan Chase & Co., 5.84% (increased by 0.91pp from prior filing) Read: An internal JPMorgan entity restructuring triggered a "ceased notifiable interest" filing, but the consolidated aggregate position actually grew, establishing a fresh notifiable aggregate at 5.84% in the global express logistics operator.

πŸ†• NEW ENTRY β€” 3759 Pharmaron Beijing (H) ← AIH Capital Group Limited / AIHC Master Fund / Wei Zhang, 5.04% (first 5% disclosure; bought 332,000 shares @ HKD 17.29 for ~HKD 5.7M) Read: AIH Capital Group, through its AIHC Master Fund and ultimately controlled by Wei Zhang, disclosed a freshly accumulated 5%+ stake in Pharmaron Beijing's H-shares across three simultaneous ownership-chain filings.

πŸ†• NEW ENTRY β€” 1024 Kuaishou Technology / 6 Power Assets Holdings / 6869 Yangtze Optical Fibre & Cable (H) / 576 Zhejiang Expressway (H) ← BlackRock, Inc. (four concurrent filings, 2026-05-28)


🏒 BUYBACK β€” 6881 China Galaxy Securities (H) ← BlackRock, Inc., 4.88% (decreased by 0.59pp) Read: China Galaxy's share repurchase program diluted BlackRock's relative stake to 4.88%; no selling action by BlackRock is implied.

🏒 BUYBACK β€” 620 DTXS Silk Road Investment Holdings ← China CITIC Financial AMC International Holdings, 0.00% (decreased by 51.00pp) Read: DTXS Silk Road's buyback absorbed CITIC's entire notifiable position, bringing it to zero β€” the extraordinary 51pp drop reflects CITIC tendering shares back to the issuer rather than an open-market disposal.

🏒 BUYBACK β€” 3347 Tigermed (H) ← JPMorgan Chase & Co., 15.95% (decreased by 0.74pp) Read: Tigermed's ongoing repurchase program passively trimmed JPMorgan's reported percentage with no change in JPMorgan's absolute share count.

🏒 BUYBACK β€” 3898 CRRC Times Electric (H) / 1157 Zoomlion Heavy Industry (H) ← BlackRock, Inc.


βš™οΈ OPTION/CONVERSION β€” 679 Asia Tele-Net and Technology ← Anatole Investment Management Limited, 9.01% (decreased by 1.49pp); subscribed 5,650,000 new shares @ HKD 13.02 for ~HKD 73.6M Read: Anatole committed HKD 73.6M to subscribe new Asia Tele-Net shares yet saw its percentage fall, as a larger concurrent issuance to other parties caused net dilution to its relative stake.

Discussion

No comments yet.

No redactions applied.

Published via wiis. Originals are encrypted at rest; this page reflects the redacted version. report abuse.